title: Heterotopic vascularized murine cardiac transplantation to study graft arteriopathy.
abstract: The development of microsurgical techniques has facilitated the establishment of fully vascularized cardiac transplantation models in small mammals. A particularly useful model that has evolved for the study of cardiac allograft vasculopathy (CAV) is a heterotopic (abdominal) vascularized murine cardiac transplantation model. Using this model has permitted the elucidation of genetic, immune and non-immune factors contributing to the development of this inexorable pathological condition, which compromises half of all human cardiac transplants. This protocol details methods for performing the transplant, histomorphometric assessment of the graft vasculature and functional evaluation of the transplanted heart. In experienced hands, the surgical procedure requires approximately 75 min to complete, and vasculopathy results are obtained at 2 months. This model entails a fully vascularized implantation technique in which the donor ascending aorta and pulmonary artery are sutured end-to-side to the recipient abdominal aorta and inferior vena cava, respectively. As this model reliably reproduces immunological and non-immunological features of CAV, investigators can thoroughly explore contributory mechanisms, diagnostic modalities and therapeutic approaches to its mitigation.
authors.affiliation: Department of Internal Medicine, and the University of Michigan Cardiovascular Center, Ann Arbor, Michigan 48109, USA.
authors.forename: Tomomi
authors.initials: T
authors.lastname: Hasegawa
authors.forename: Scott H
authors.initials: SH
authors.lastname: Visovatti
authors.forename: Matthew C
authors.initials: MC
authors.lastname: Hyman
authors.forename: Takanori
authors.initials: T
authors.lastname: Hayasaki
authors.forename: David J
authors.initials: DJ
authors.lastname: Pinsky
mesh_terms: D000818:Animals; D003327:Coronary Disease / Q000209:etiology* / Q000473:pathology; D004195:Disease Models, Animal; D016027:Heart Transplantation / Q000009:adverse effects / Q000379:methods*; D051379:Mice; D008866:Microsurgery / Q000379:methods*; D016042:Transplantation, Heterotopic / Q000379:methods*; D014184:Transplantation, Homologous / Q000009:adverse effects*